Autolus Therapeutics
Entity

  • Autolus Therapeutics

    Created in 2014


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    29,043

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    The MediaWorks, 191 Wood Ln, London W12 7FP, UK

    London

    United Kingdom

  • Employees

    Scale: 501-1000

    Estimated: 685

  • Engaged catalyst

    0
    0 0

  • Added in Motherbase

    1 year, 1 month ago
Description
  • Value proposition

    Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer

    Autolus is a CAR T cell therapy company. We are applying our extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing therapies to patients with cancer and autoimmune diseases.

  • Autolus - developing CAR T cell therapies for patients with cancer and autoimmune diseases

    Autolus is a CAR T cell therapy company which develops advanced autologous T cell therapies that have the potential to deliver life-changing benefits to patients with cancer and autoimmune diseases

    • https://www.autolus.com/
  • Website is disabled or domain is for sale
Catalyst interactions
Catalyst TypeTweets Articles
No interactions
Social network dynamics
Similar entities
BETA
Last news
Show all articles